XML 59 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes - Schedule of Gross Deferred Tax Asset and Related Valuation Allowance (Detail) - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Deferred tax assets:    
Net operating loss carryforward $ 41,687,577 $ 30,813,509
Capitalized start-up costs 1,501,895 1,695,688
Patent amortization 119,888 135,358
Research and orphan drug credits 28,123,082 21,293,509
Deferred rent 51,400 71,938
Deferred compensation 3,293,221 2,274,885
Other 95,564 69,906
Total gross deferred tax assets 74,872,627 56,354,793
Valuation allowance (74,872,627) (56,354,793)
Deferred tax assets
Deferred tax liabilities:    
Total deferred tax liabilities
Net deferred tax assets